M512-0349 Screening compound: 4-{1H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-5-sulfonyl}-3,5-dimethyl-1,2-oxazole

M512-0349 Screening compound: 4-{1H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-5-sulfonyl}-3,5-dimethyl-1,2-oxazole
M512-0349 Screening compound: 4-{1H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-5-sulfonyl}-3,5-dimethyl-1,2-oxazole alternative view

Chemical Structure Depiction of ChemDiv screening compound M512-0349
4-{1H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-5-sulfonyl}-3,5-dimethyl-1,2-oxazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M512-0349

Molecular Formula

C11H14N4O3S (C11 H14 N4 O3 S)

Compound Name

4-{1H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-5-sulfonyl}-3,5-dimethyl-1,2-oxazole

IUPAC name

4-{1H4H5H6H7H-imidazo[45-c]pyridine-5-sulfonyl}-35-dimethyl-12-oxazole

SMILES

Cc1noc(C)c1S(N(CC1)Cc2c1[nH]cn2)(=O)=O

InChI

InChI=1S/C11H14N4O3S/c1-7-11(8(2)18-14-7)19(16,17)15-4-3-9-10(5-15)13-6-12-9/h6H,3-5H2,1-2H3,(H,12,13)

InChI Key

VGFBEWNRDBIMKD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27545941

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

282.32

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

-0.188

Distribution Coefficient, logD

-2.521

Water Solubility, LogSw

-1.92

Polar Surface Area

77.479

Acid Dissociation Constant (pKa)

14.41

Base Dissociation Constant (pKb)

9.73

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.50

M512-0349 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
  • Others
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • Epigenetic
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with M512-0349 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M512-0349?
Check Price and Availability of M512-0349, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M512-0349 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M512-0349
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M512-0349
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M512-0349 available by request